Fundraising Fox
Atria Ventures
Venture capitalSan Francisco · Pre-Seed–Seed · 1 people tracked
Also known as Atria
Find your way into Atria Ventures
Sign up to see every warm intro you have to Atria Ventures
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Atria Ventures team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Investment thesis
Atria Ventures backs founders working at the edge of computation and biology within the life sciences. Operating as a solo capitalist vehicle, it invests up to $3M at inception and seed, positioning itself as an early and often first believer in technical teams. The firm emphasizes being 'never too early' to engage, supporting companies applying AI and computational approaches to drug discovery, genomics, clinical workflows, biomanufacturing, and biopharma. Its portfolio spans techbio and AI-driven life science startups.
Source: firm website, verified Oct 2, 2026.
Team · 1 people
from public directories
What they invest in
from 15 of 15 portfolio companiesAI & Machine Learning ×13Biotech ×12Healthtech ×5Data & Infrastructure ×4Digital Health ×4Deep Tech ×3Medical Devices ×3Crypto & Web3 ×2
HQs:United States×5
Investments · 15 tracked
founders shown can be your intro pathBy year:2025 · 32024 · 14 dated
Abridge builds AI software that converts clinical conversations into structured insights for healthcare providers.
AI & Machine LearningDigital HealthHealthtechPhiladelphia, US
Shiv Rao(CEO, Co-Founder)inSandeep Konam(Founder)inJulia Chapin(Founder)Sagar Sanghvi(Executive Officer)inFlorian Metze(Founder)Shivdev Rao(Founder)
PartnerChris Leiter· solo GP
Co-investorsAlpha Square Groupalphabet angelsAndreessen HorowitzBessemer Venture PartnersCapitalGCatalio Capital Management, LP+27 more
Axi.om uses agentic intelligence and AI to predict, explain, and fix drug toxicity early in development by leveraging the largest experimental-to-clinical dataset of profiled molecules linked to human clinical outcomes.
AI & Machine LearningBiotechMedical Devices
Alex Beatson(Founder)Brandon White(Founder)
PartnerChris Leiter· solo GP
Co-investorsAbstract VenturesAmplify PartnersCRV (Charles River Ventures)GaingelsInception Studio CapitalMana Ventures+1 more
__Twitter.png)
Chai Discovery builds a computer-aided design suite using artificial intelligence to design new molecules and drugs.
AI & Machine LearningBiotechDeep TechSan Francisco, US
Joshua Meier(Founder)inJack Dent(Founder)inJosh Meier(CEO)Jacques Boitreaud(Founder)Jacques Boutreau(Founder)Joshua Meier Jack Dent(Founder)
PartnerChris Leiter· solo GP
Co-investorsAmplify PartnersAvenir Growth CapitalavraBain Capital VenturesBattery VenturesDCVC (Data Collective)+30 more
Evolv Life develops orally-delivered biomimetic peptides that activate the body's own GLP-1 and GIP pathways to support appetite control, weight loss, and metabolic health without prescriptions or stimulants.
BiotechDirect to ConsumerWellness & Fitness
Co-investorsAnthropy PartnersFelicis VenturesGeneral CatalystJAZZ Venture PartnersJuniperSeed Capital Bizkaia SA+5 more
.png)
.jpeg){kind=logo}
Forus embeds into physician workflows to automate the steps between a clinical decision and a patient starting treatment, including insurance authorization, financial assistance, and fulfillment routing across drugs, payers, and pharmacies.
AI & Machine LearningDigital HealthHealthtechSaaS
Sahir Jaggi(Founder)in
PartnerChris Leiter· solo GP
Co-investorsAccelavraBain Capital VenturesBoxGroupGeneral CatalystPear VC+2 more
HairDAO is a decentralized research network enabling patients and researchers to collaboratively fund and develop new hair loss treatments through community voting and blockchain-based governance.
BiotechCrypto & Web3Medical Devices
Andrew Verbinnen(Founder)inAndrew Bakst(Founder)in
Co-investorsCompoundMoonlanding Ventures
HoX develops hardware, software, and chemistry capabilities to integrate biological analysis into business and health applications.
AI & Machine LearningBiotechData & InfrastructureDeep TechHealthtechSpokane, US
Phil Hofer(CTO & Cofounder)James van Alstine(CEO & Cofounder)
Co-investorsHAWKTAIL
Molecule operates a blockchain-based platform supporting decentralized science (DeSci), funding research projects and connecting scientists and entrepreneurs.
AI & Machine LearningBiotechCrypto & Web3
Paul Kohlhaas(Founder)inNeeta Singal(Founder)Saurabh Singal(Founder)Saurabh Singal Neeta Singal(Founder)Tyler Golato(Founder)Vincent Weisser(Founder)in
Co-investorsBackedBoxGroupCompoundFifty YearsGaingelsIncrypt Blockchain+14 more
Orchestra is a platform that unifies scientific, operational, and financial data into a single intelligent environment serving biotech and research teams.
AI & Machine LearningBiotechEnterprise Software
Ashoka Rajendra(CEO, Orchestra)inAndy Xu(CTO, Orchestra)in
Co-investors8VCAndreessen HorowitzMoonfire Ventures
Peer AI builds AI-powered tools for drug development and clinical research, with a focus on medical writing and regulatory work.
AI & Machine LearningBiotechDigital HealthSaaS
Anita Modi(Co-Founder & CEO)inChris Ceppi(Co-Founder, CTO & COO)Ravi Ramachandran(Co-Founder & Chief Scientific and Regulatory Officer)in
PartnerChris Leiter· solo GP
Co-investorsAlumni VenturesFlare Capital PartnersGaingelsGreycroftMana VenturesSignalFire
ReSync Bio provided drug discovery teams with no-code access to AI tools for molecular design and analysis, removing the need to build their own infrastructure.
AI & Machine LearningBiotechDeep Tech
MihirNishanthLindsayTonyChelsea
Co-investorsCaffeinated Capital
Sleuth provides evidence-backed answers for biopharma decision-making, built on a knowledge graph that maps over a billion relationships across biology, clinical evidence, competitive dynamics, and deal history.
AI & Machine LearningBiotechData & InfrastructureFintechSan Francisco, US
Andrew Pannu(Executive Officer, Director)
BoardCaleb Appleton(Director)inMark Jacobstein(Director)
PartnerChris Leiter· solo GP
Co-investorsBison VenturesHAWKTAIL
Specie Bio operates BioExchange, an AI-driven platform for finding, matching, and accessing biospecimens and multimodal clinical data from a global network of biobanks, hospitals, clinics, and non-profit institutions.
AI & Machine LearningBiotechData & Infrastructure
Trially uses AI and data science to match patients with clinical trials and accelerate trial recruitment.
AI & Machine LearningDigital HealthHealthtechMedical DevicesKansas City, US
Kyle McAllister(CEO & Founder)inTrevor Welch(Executive Officer, Director)in
BoardThad Langford(Director)in
Co-investorsAlpaca VCCorigin VenturesFlyover CapitalGaingelsRedbud VCThe Council+2 more
Portfolio news
latest coverage across their companiesForus · citybiz.co · Sep 9, 2026
Chai Discovery · siliconangle.com · Jul 14, 2026
Sleuth Insights · intelligence360.news · Nov 3, 2025
Peer AI · prnewswire.com · Oct 7, 2025
Trially · finsmes.com · Sep 17, 2025
Frequently asked questions
- How many investments has Atria Ventures made?
- Atria Ventures has 15 tracked investments, including 3 dated in the last 24 months.
- What stage does Atria Ventures invest at?
- Atria Ventures invests at the Pre-Seed, Seed stages.
- What is Atria Ventures's typical check size?
- Atria Ventures typically writes checks of $500K – $3M.
- What sectors does Atria Ventures focus on?
- Atria Ventures focuses on AI & Machine Learning, Biotech, Deep Tech, Digital Health, Hardware, Healthtech, New Materials.
- Where is Atria Ventures located?
- Atria Ventures is headquartered in San Francisco, US.
- Does Atria Ventures lead rounds?
- Yes, Atria Ventures leads investment rounds.
- Who does Atria Ventures co-invest with?
- Atria Ventures most often shares deals with Gaingels, 8VC, Andreessen Horowitz, among 61 tracked co-investors.
Images
Similar investors
Snatched Ventures is a San Francisco-based early-stage venture capital firm backing DeepTech startups focused on sustainable innovation and operational transformation. It is led by a two-GP team combining corporate development and institutional investment management experience.
OUP (Osage University Partners) is a venture firm that invests in science-driven startups commercializing deep technology innovations emerging from university research and breakthrough science.
Washington Research Foundation (WRF) and its investment arm WRF Capital support research and startups in Washington state, providing grants to nonprofit research institutions and making venture investments in Washington-based startups.
The Global Startup Acceleration Program (GSAP) is a JETRO initiative, run with Japan's Cabinet Office and top overseas accelerators, that helps Japan-based startups pursue international business development through tailored, equity-free accelerator courses.
Redstart Ventures (Redstart Labs) is a deeptech investment arm associated with InfoEdge, focused on the emerging frontier where computation, biology, and materials converge.